Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tom J. Brett is active.

Publication


Featured researches published by Tom J. Brett.


Structure | 2002

Accessory protein recruitment motifs in clathrin-mediated endocytosis.

Tom J. Brett; Linton M. Traub; Daved H. Fremont

Clathrin-mediated endocytosis depends upon the interaction of accessory proteins with the alpha-ear of the AP-2 adaptor. We present structural characterization of these regulatory interactions. DPF and DPW motif peptides derived from eps15 and epsin bind in type I beta turn conformations to a conserved pocket on the alpha-ear platform. We show evidence for a second binding site that is DPW motif specific. The structure of a complex with an AP-2 binding segment from amphiphysin reveals a novel binding motif that we term FxDxF, which is engaged in an extended conformation by a unique surface of the platform domain. The FxDxF motif is also used by AP180 and the 170 kDa isoform of synaptojanin and can be found in several potential endocytic proteins, including HIP1, CD2AP, and PLAP. A mechanism of clathrin assembly regulation is suggested by three different AP-2 engagement modes.


Cell Host & Microbe | 2014

Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1.

Wei Xu; Megan R. Edwards; Dominika Borek; Alicia R. Feagins; Anuradha Mittal; Joshua B. Alinger; Kayla N. Berry; Benjamin Yen; Jennifer R. Hamilton; Tom J. Brett; Rohit V. Pappu; Daisy W. Leung; Christopher F. Basler; Gaya K. Amarasinghe

During antiviral defense, interferon (IFN) signaling triggers nuclear transport of tyrosine-phosphorylated STAT1 (PY-STAT1), which occurs via a subset of karyopherin alpha (KPNA) nuclear transporters. Many viruses, including Ebola virus, actively antagonize STAT1 signaling to counteract the antiviral effects of IFN. Ebola virus VP24 protein (eVP24) binds KPNA to inhibit PY-STAT1 nuclear transport and render cells refractory to IFNs. We describe the structure of human KPNA5 C terminus in complex with eVP24. In the complex, eVP24 recognizes a unique nonclassical nuclear localization signal (NLS) binding site on KPNA5 that is necessary for efficient PY-STAT1 nuclear transport. eVP24 binds KPNA5 with very high affinity to effectively compete with and inhibit PY-STAT1 nuclear transport. In contrast, eVP24 binding does not affect the transport of classical NLS cargo. Thus, eVP24 counters cell-intrinsic innate immunity by selectively targeting PY-STAT1 nuclear import while leaving the transport of other cargo that may be required for viral replication unaffected.


Cell | 2002

Structural Basis of Chemokine Sequestration by a Herpesvirus Decoy Receptor

Jennifer M. Alexander; Christopher A. Nelson; Victor van Berkel; Elaine K. Lau; Joey M. Studts; Tom J. Brett; Samuel H. Speck; Tracy M. Handel; Herbert W. Virgin; Daved H. Fremont

The M3 protein encoded by murine gamma herpesvirus68 (gamma HV68) functions as an immune system saboteur by the engagement of chemoattractant cytokines, thereby altering host antiviral inflammatory responses. Here we report the crystal structures of M3 both alone and in complex with the CC chemokine MCP-1. M3 is a two-domain beta sandwich protein with a unique sequence and topology, forming a tightly packed anti-parallel dimer. The stoichiometry of the MCP-1:M3 complex is 2:2, with two monomeric chemokines embedded at distal ends of the preassociated M3 dimer. Conformational flexibility and electrostatic complementation are both used by M3 to achieve high-affinity and broad-spectrum chemokine engagement. M3 also employs structural mimicry to promiscuously sequester chemokines, engaging conservative structural elements associated with both chemokine homodimerization and binding to G protein-coupled receptors.


Nature Immunology | 2004

N-domain–dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation

Naruhisa Ota; Tom J. Brett; Theresa L. Murphy; Daved H. Fremont; Kenneth M. Murphy

The N-terminal protein interaction domain (N-domain) of the signal transducer and activator of transcription-4 (STAT4) is believed to stabilize interactions between two phosphorylated STAT4 dimers to form STAT4 tetramers. Here, we show that nonphosphorylated STAT4 dimers form in vivo before cytokine receptor–driven activation. Mutations in the N-domain dimerization interface abolished assembly of nonphosphorylated STAT4 dimers and prevented STAT4 phosphorylation mediated by cytokine receptors. In addition, N-domain dimerization occurred for other STAT family members but was homotypic in character. This implies a conserved role for N-domain dimerization, which might include influencing interactions with cytokine receptors, favoring homodimer formation or accelerating formation of the phosphorylated STAT dimer.


Journal of Clinical Investigation | 2012

IL-13–induced airway mucus production is attenuated by MAPK13 inhibition

Yael G. Alevy; Anand C. Patel; Arthur G. Romero; Dhara A. Patel; Jennifer Tucker; William T. Roswit; Chantel A. Miller; Richard F. Heier; Derek E. Byers; Tom J. Brett; Michael J. Holtzman

Increased mucus production is a common cause of morbidity and mortality in inflammatory airway diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. However, the precise molecular mechanisms for pathogenic mucus production are largely undetermined. Accordingly, there are no specific and effective anti-mucus therapeutics. Here, we define a signaling pathway from chloride channel calcium-activated 1 (CLCA1) to MAPK13 that is responsible for IL-13-driven mucus production in human airway epithelial cells. The same pathway was also highly activated in the lungs of humans with excess mucus production due to COPD. We further validated the pathway by using structure-based drug design to develop a series of novel MAPK13 inhibitors with nanomolar potency that effectively reduced mucus production in human airway epithelial cells. These results uncover and validate a new pathway for regulating mucus production as well as a corresponding therapeutic approach to mucus overproduction in inflammatory airway diseases.


Annual Review of Physiology | 2009

The Role of CLCA Proteins in Inflammatory Airway Disease

Anand C. Patel; Tom J. Brett; Michael J. Holtzman

Inflammatory airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) exhibit stereotyped traits that are variably expressed in each person. In experimental mouse models of chronic lung disease, these individual disease traits can be genetically segregated and thereby linked to distinct determinants. Functional genomic analysis indicates that at least one of these traits, mucous cell metaplasia, depends on members of the calcium-activated chloride channel (CLCA) gene family. Here we review advances in the biochemistry of the CLCA family and the evidence of a role for CLCA family members in the development of mucous cell metaplasia and possibly airway hyperreactivity in experimental models and in humans. On the basis of this information, we develop the model that CLCA proteins are not integral membrane proteins with ion channel function but instead are secreted signaling molecules that specifically regulate airway target cells in healthy and disease conditions.


Nature Structural & Molecular Biology | 2006

Structural definition of the F-actin-binding THATCH domain from HIP1R.

Tom J. Brett; Valerie Legendre-Guillemin; Peter S. McPherson; Daved H. Fremont

Huntingtin-interacting protein-1 related (HIP1R) has a crucial protein-trafficking role, mediating associations between actin and clathrin-coated structures at the plasma membrane and trans-Golgi network. Here, we characterize the F-actin–binding region of HIP1R, termed the talin-HIP1/R/Sla2p actin-tethering C-terminal homology (THATCH) domain. The 1.9-Å crystal structure of the human HIP1R THATCH core reveals a large sequence-conserved surface patch created primarily by residues from the third and fourth helices of a unique five-helix bundle. Point mutations of seven contiguous patch residues produced significant decreases in F-actin binding. We also show that THATCH domains have a conserved C-terminal latch capable of oligomerizing the core, thereby modulating F-actin engagement. Collectively, these results establish a framework for investigating the links between endocytosis and actin dynamics mediated by THATCH domain–containing proteins.


Journal of Biological Chemistry | 2011

Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release

Melissa Swiecki; Suzanne Scheaffer; Marc Allaire; Daved H. Fremont; Marco Colonna; Tom J. Brett

BST-2/tetherin is a host antiviral molecule that functions to potently inhibit the release of enveloped viruses from infected cells. In return, viruses have evolved antagonists to this activity. BST-2 traps budding virions by using two separate membrane-anchoring regions that simultaneously incorporate into the host and viral membranes. Here, we detailed the structural and biophysical properties of the full-length BST-2 ectodomain, which spans the two membrane anchors. The 1.6-Å crystal structure of the complete mouse BST-2 ectodomain reveals an ∼145-Å parallel dimer in an extended α-helix conformation that predominantly forms a coiled coil bridged by three intermolecular disulfides that are required for stability. Sequence analysis in the context of the structure revealed an evolutionarily conserved design that destabilizes the coiled coil, resulting in a labile superstructure, as evidenced by solution x-ray scattering displaying bent conformations spanning 150 and 180 Å for the mouse and human BST-2 ectodomains, respectively. Additionally, crystal packing analysis revealed possible curvature-sensing tetrameric structures that may aid in proper placement of BST-2 during the genesis of viral progeny. Overall, this extended coiled-coil structure with inherent plasticity is undoubtedly necessary to accommodate the dynamics of viral budding while ensuring separation of the anchors.


Nature Communications | 2016

Data publication with the structural biology data grid supports live analysis

Peter Meyer; Stephanie Socias; Jason Key; Elizabeth Ransey; Emily C. Tjon; Alejandro Buschiazzo; Ming Lei; Chris Botka; James Withrow; David Neau; Kanagalaghatta R. Rajashankar; Karen S. Anderson; Richard H. G. Baxter; Stephen C. Blacklow; Titus J. Boggon; Alexandre M. J. J. Bonvin; Dominika M. Borek; Tom J. Brett; Amedeo Caflisch; Chung I. Chang; Walter J. Chazin; Kevin D. Corbett; Michael S. Cosgrove; Sean Crosson; Sirano Dhe-Paganon; Enrico Di Cera; Catherine L. Drennan; Michael J. Eck; Brandt F. Eichman; Qing R. Fan

Access to experimental X-ray diffraction image data is fundamental for validation and reproduction of macromolecular models and indispensable for development of structural biology processing methods. Here, we established a diffraction data publication and dissemination system, Structural Biology Data Grid (SBDG; data.sbgrid.org), to preserve primary experimental data sets that support scientific publications. Data sets are accessible to researchers through a community driven data grid, which facilitates global data access. Our analysis of a pilot collection of crystallographic data sets demonstrates that the information archived by SBDG is sufficient to reprocess data to statistics that meet or exceed the quality of the original published structures. SBDG has extended its services to the entire community and is used to develop support for other types of biomedical data sets. It is anticipated that access to the experimental data sets will enhance the paradigm shift in the community towards a much more dynamic body of continuously improving data analysis.


Journal of Experimental Medicine | 2015

TREM-2 promotes macrophage survival and lung disease after respiratory viral infection

Kangyun Wu; Derek E. Byers; Xiaohua Jin; Eugene Agapov; Jennifer Alexander-Brett; Anand C. Patel; Marina Cella; Susan Gilfilan; Marco Colonna; Daniel L. Kober; Tom J. Brett; Michael J. Holtzman

Wu et al. use a mouse model to show that active respiratory viral infection triggers TREM-2 expression on the macrophage cell surface and thereby prevents macrophage apoptosis during the acute illness. In addition, long after viral clearance, IL-13 and DAP12 promote TREM-2 cleavage to its soluble form that unexpectedly also enhances macrophage survival and promotes chronic inflammatory disease.

Collaboration


Dive into the Tom J. Brett's collaboration.

Top Co-Authors

Avatar

Michael J. Holtzman

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Daniel L. Kober

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Zeynep Yurtsever

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Anand C. Patel

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

John J. Stezowski

University of Nebraska–Lincoln

View shared research outputs
Top Co-Authors

Avatar

Monica Sala-Rabanal

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Colin G. Nichols

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Daved H. Fremont

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Jennifer M. Alexander

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Arthur G. Romero

Washington University in St. Louis

View shared research outputs
Researchain Logo
Decentralizing Knowledge